Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001457716-16-000085
Filing Date
2016-02-03
Accepted
2016-02-03 12:42:08
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 13G LGNDZ kcg13g.htm SC 13G 160234
  Complete submission text file 0001457716-16-000085.txt   162050
Mailing Address 11119 NORTH TORREY PINES ROAD SUITE 200 LA JOLLA CA 92037
Business Address 11119 NORTH TORREY PINES ROAD SUITE 200 LA JOLLA CA 92037 858-550-7500
LIGAND PHARMACEUTICALS INC (Subject) CIK: 0000886163 (see all company filings)

EIN.: 770160744 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-43329 | Film No.: 161383970
SIC: 2834 Pharmaceutical Preparations

Mailing Address 545 WASHINGTON BLVD. JERSEY CITY NJ 07310
Business Address 545 WASHINGTON BLVD. JERSEY CITY NJ 07310 201-356-1390
KCG AMERICAS LLC (Filed by) CIK: 0001457716 (see all company filings)

EIN.: 264219373 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G